查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
聲音/語音生物標記市場 - 全球及區域分析：按平台類型、適應症類型、應用類型、最終用戶及區域 - 分析與預測（2025-2035）
市場調查報告書
商品編碼
1802931

聲音/語音生物標記市場 - 全球及區域分析：按平台類型、適應症類型、應用類型、最終用戶及區域 - 分析與預測（2025-2035）

Voice/Vocal Biomarker Market - A Global and Regional Analysis: Focus on Platform Type, Application, Indication, End User, and Regional Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 131 Pages | 商品交期: 1-5個工作天內

價格

聲音/語音生物標記是指源自人類聲音特徵的生物標記的開發、商業化和應用，以檢測、監測和預測健康狀況。

聲音/語音生物標記是數位生物標記的子集，是可測量的聲音特徵，例如音高、音調、頻率、幅度、語速和震顫，與生理或病理狀況相關，實現非侵入性診斷和監測。聲音/語音生物標記市場包括軟體平台、阿茲海默症演算法、硬體診斷工具以及整合遠距醫療解決方案，這些解決方案可捕獲和分析語音資料以識別疾病的早期徵兆，例如神經系統疾病（例如帕金森氏症、阿茲海默症）、精神遠端醫療狀況（例如憂鬱症、焦慮症）、呼吸系統疾病、心血管疾病和認知能力下降。還涵蓋健康、認知健身、國防和職業健康的應用。該市場的成長得益於技術進步、對遠距醫療解決方案日益成長的需求以及語音分析與傳統診斷方法相比提供快速、可擴展且經濟高效的篩檢的能力。

主要市場統計資料
預測期 2025-2035
2025年評估 12.435億美元
2035年的預測 53.977億美元
年複合成長率 15.81%

市場介紹

全球聲音/語音生物標記市場預計將大幅擴張，到2035年將達到 53.977億美元。

聲音/語音生物標記是一種診斷和監測各種健康狀況的全新創新方法，主要透過分析語音模式和聲音來實現。隨著人工智慧（AI）、機器學習和自然語言處理（NLP）的進步，診斷工具變得更加精準、非侵入式，該領域迅速發展。

聲音/語音生物標記市場中的公司，包括 Sonde Health、Canary Speech 和 Winterlight，利用人工智慧主導的演算法分析語音模式，以檢測神經系統、精神系統和認知障礙。這些解決方案評估音高、音調、節奏和速度等語音特徵，以識別阿茲海默症、帕金森氏症、憂鬱症和焦慮症等疾病的早期徵兆。

聲音/語音生物標記物正擴大用於監測認知障礙和其他神經系統疾病。能夠檢測聲音/語音模式的細微變化，有助於早期療育並更準確地追蹤病情進展，顯著改善失智症和其他與老齡化相關的認知障礙的管理。

聲音生物標記技術的一大優勢在於其非侵入性。與需要侵入性操作或大量檢測的傳統診斷工具不同，聲音生物標記利用簡短的錄音（通常僅 30-40 秒）來檢測健康問題的早期指標，這使得其易於進行持續監測，尤其是在偏遠地區。

聲音/語音生物標記市場的主要企業建立策略夥伴關係關係，以增強自身能力並擴大市場佔有率。例如，Sonde Health 與高通合作，將其語音生物標記技術整合到行動平台，實現基於設備的日常健康監測。此外，Winterlight 被 Cambridge Cognition 收購，也促使人們越來越重視透過語音分析來偵測認知障礙。

音訊生物標記技術與醫療保健系統的整合正變得越來越廣泛，並應用於遠端醫療、心理健康和認知健康監測。這些工具擴大用於臨床環境、患者健康計劃和研究，以經濟高效且及時的方式追蹤健康狀況並檢測疾病的早期症狀。

由於對創新非侵入式診斷解決方案的需求不斷成長，聲音/語音生物標記市場迎來大量投資。預計未來幾年，全球聲音/語音生物標記市場將繼續快速擴張，其應用範圍將超越神經和心理健康領域，擴展到慢性阻塞性肺病（COPD）等慢性疾病以及壓力等級檢測。

儘管語音生物標記前景光明，但人們對資料隱私和語音資料的倫理使用仍心存疑慮。由於這些技術會收集個人健康的敏感訊息，因此《一般資料保護規範》（GDPR）和《健康保險流通與責任法案》（HIPAA）等法規對於隱私權保護非常重要。該領域的公司致力於確保其解決方案符合資料保護法，並確保用戶資料得到安全處理。

摘要，全球聲音/語音生物標記市場定位於醫療保健領域的變革性工具，為各種健康狀況的早期檢測和持續監測提供非侵入性、便捷且可擴展的解決方案。隨著技術的進步，語音生物標記融入常規健康應用，有望顯著改善患者預後並提高醫療效率。

聲音/語音生物標記物市場正日益用於監測和診斷各種疾病，包括神經退化性疾病（如帕金森氏症和阿茲海默症）、精神疾病（如憂鬱症和焦慮症）以及呼吸系統疾病（如氣喘和慢性阻塞性肺病）。例如，某些語音變化可能預示著早期帕金森氏症，而這種疾病傳統上很難診斷。

基於語音的身份驗證：在安全和身份驗證非常重要的行業中，語音生物標記用於語音生物識別技術。語音生物辨識技術透過分析人的聲音並檢查其獨特特徵（例如口音、語調和說話節奏）來驗證身份。它廣泛應用於銀行、通訊和政府部門。

影響：啟用免持身分驗證可提高安全性、減少詐欺並改善使用者體驗。

在客戶支援、客服中心和虛擬助理（如 Alexa 和 Siri）中，語音生物標記可以幫助檢測沮喪、快樂和壓力等情緒，使企業能夠根據客戶的情緒狀態客製化回應或將客戶轉介給專門的代理商。

市場區隔

細分1：依平台類型

  • 雲端基礎
  • 基於網路

依平台類型分類，雲端基礎將繼續成為全球聲音/語音生物標記市場中的領先細分市場，到2024年將佔據 79.99%的市場佔有率，預計在2025-2035年預測期內的年複合成長率為 16.0%。

全球聲音/語音生物標記市場中的雲端基礎平台改變語音資料的收集、儲存、處理和分析方式。這些平台提供處理大量語音資料和應用人工智慧演算法進行診斷和監控所需的基礎設施和運算能力。用於語音生物標記分析的雲端基礎平台的出現再形成健康診斷和遠端患者監護的格局。這些平台利用人工智慧和機器學習的力量來解讀語音資料，並將聲音特徵轉化為可操作的健康洞察。利用可擴展的雲端基礎設施可以實現即時、遠端和大規模分析，提高臨床醫生、研究人員和數位健康創新者的可近性。

細分2：依適應症類型

  • 神經系統疾病
  • 精神疾病
  • 呼吸系統疾病
  • 心血管疾病
  • 其他

從適應症類型來看，全球聲音/語音生物標記市場主要由精神健康障礙細分市場驅動，2024年該細分市場佔據 33.51%的市場佔有率。由於對情緒和心理健康非侵入式即時監測的需求日益成長，精神健康障礙適應症在聲音/語音生物標記市場中佔據主導地位。語音分析可以透過分析音調、音高和說話模式來檢測壓力、焦慮、憂鬱症和其他心理健康狀況。例如，Ellipsis Health 等公司開發了人工智慧平台，可透過語音記錄評估心理健康狀況，實現及時干預並改善心理健康服務的可及性。這種方法因其易用性和擴充性而越來越受歡迎。

細分 3：依應用類型

  • 診斷
  • 監控
  • 臨床研究
  • 其他

從應用類型來看，全球聲音/語音生物標記市場由診斷驅動，佔據主導地位。聲帶生物標記市場的診斷應用受到該技術的非侵入性、檢測疾病早期徵兆的能力以及在持續監測患者健康方面的作用的驅動。隨著人工智慧、機器學習和遠距醫療的進步，語音生物標記提供了一種經濟高效、可擴展且易於獲取的解決方案，提高了疾病檢測的準確性和及時性，尤其是在神經系統和呼吸系統疾病方面。隨著臨床檢驗的進展以及該技術被整合到醫療保健系統中，語音生物標記的診斷應用預計將進一步擴展，為患者和醫療保健提供者帶來顯著的益處。

細分 4：依最終用戶

  • 醫院
  • CRO
  • 研究機關

從終端用戶來看，全球聲音/語音生物標記市場將由醫院和診所主導，到2024年將佔據47.02%的市場佔有率。醫院在語音生物標記市場佔據主導地位，這得益於以下幾項戰略屬性：致力於診斷、擁有龐大的資料儲存庫、精通監管框架、擁有雄厚的資金支持以及在醫療保健網路中享有的信任。醫院擁有先進的基礎設施、跨部門的協同效應以及接觸大量患者群體的優勢，使其成為語音生物標記創新開發、檢驗和商業化的首選合作夥伴。隨著這些技術不斷發展和成熟，醫院將繼續引領這一新興領域的臨床應用和創新。

細分5：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
  • 中東和非洲

全球聲音/語音生物標記市場在亞太地區迅速擴張。預計亞太地區聲音/語音生物標記市場將經歷強勁成長，尤其得益於人工智慧和機器學習在行動醫療設備、穿戴式裝置和遠端醫療服務中的整合。然而，為了確保長期永續性和廣泛應用，需要解決法律規範和資料隱私問題。

對於亞太國家而言，中國憑藉其龐大的人口和快速的技術採用佔據該地區最大的市場佔有率，而印度則由於醫療保健投資的增加和慢性病負擔的增加而成為成長最快的市場之一。

Sonde Health、Beyond Verbal、Cogito Corporation 和 Vocalis Health 等主要企業透過整合人工智慧技術來增強其聲音/語音解決方案的功能，引領市場。

全球聲音/語音生物標記市場的最新趨勢

  • 6月 25 日，Beyond Verbal 與梅奧診所合作開發和檢驗用於早期阿茲海默症檢測的聲音生物標記。
  • 6月25日，Ellipsis Health 在A輪融資中籌集了4,500萬美元，由Salesforce、Khosla Ventures和CVS Health Ventures領投。這筆投資目的是為其基於AI的語音助理提供支持，用於護理管理。
  • 2月25日，諾亞財富獲得4,062.14億美元融資，用於推進心臟病的遠端監控和語音診斷。該公司探索透過分析語音音調變化，將人工智慧應用於基於語音的心臟診斷。
  • 12月22日，Sonde Health在B輪融資中完成1,925萬美元，由Partners Investment領投，NEOM Company、KT Corporation、PureTech Health和M Ventures跟主要企業。目前，該公司已資金籌措3,525萬美元，並計劃加速全球擴張。
  • 8月 22 日：Sonde Health 與 Koye Pharmaceuticals 達成多年期協議，共同開發印度慢性阻塞性肺病（COPD）的語音生物標記檢測和監測能力。

需求 - 促進因素、挑戰、機會

市場需求促進因素

  • 擴大聲音/語音生物標記作為新型診斷和監測輔助工具的應用

語音生物標記技術將徹底改變醫療保健產業。其非侵入性、經濟高效且持續性的特性使其成為早期診斷、監測病情進展和管理各種健康狀況的理想選擇。透過利用語音特徵的自然變化，臨床醫師可以深入了解患者原本難以察覺的健康狀況。隨著這些技術的不斷發展，預計將在臨床環境中得到更廣泛的應用，尤其是在人工智慧演算法的改進以及監管核准簡化語音生物標記與常規醫療保健的整合之後。語音生物標記技術作為一種創新的診斷和監測工具，正應用於各種臨床領域。

神經病學 - 帕金森氏症、阿茲海默症和多發性硬化症等神經系統疾病通常會導致言語模式的細微變化。語音分析有助於發現這些疾病的早期症狀並監測其進展。例如，聲音震顫、音調和節奏的變化可能預示著帕金森氏症的運動障礙或失智症的認知衰退。

心理健康 - 憂鬱症、焦慮和壓力等心理健康狀況會改變說話模式和語調。人工智慧演算法可以檢測與這些狀況相關的語音線索，例如語速減慢或語調平緩，促進持續監測和早期療育。這使得被動、非侵入式篩檢成為可能，例如透過簡短的語音樣本識別憂鬱症風險。

心臟病學 - 研究表明，聲音特徵可以反映心血管健康狀況。鼻塞或呼吸障礙引起的發聲變化可能預示心臟衰竭或冠狀動脈疾病。除了傳統的心臟病早期檢測和持續監測方法外，聲音生物標記也被研究。

呼吸系統疾病 - 慢性阻塞性肺病（COPD）和氣喘等呼吸系統疾病會影響患者的聲音和呼吸音。語音分析可以追蹤患者的喘息、說話時的氣短以及咳嗽模式，提供一種非侵入性的方式來監測呼吸系統健康並及早發現病情惡化。例如，語音生物標記物接受測試，透過分析語音記錄來識別肺功能下降的徵兆，幫助管理 COPD 患者。

其他臨床應用 - 聲音生物標記也被研究用於檢測糖尿病併發症、認知障礙和創傷性腦損傷，以及監測高風險職業的壓力和疲勞。在一般健康和預防醫學領域，聲音生物標記物提供了一種便捷的健康狀況監測方法，例如一些健康應用程式可以追蹤聲音相關的壓力等級，作為潛在健康問題的早期預警訊號。

註：以上所有因素均在報告中進行了詳細評估。

市場挑戰

  • 技術限制和準確性問題

聲音模式的多變性 - 人類的聲音會因情緒狀態、健康狀況、環境噪音、年齡、性別、口音等因素而有很大差異。語音生物標記系統必須考慮這些變化，以確保準確可靠的辨識。

訊號品質 - 背景噪音（例如其他聲音或環境聲音）會扭曲音訊訊號，使系統難以獲得準確的生物特徵資料。這在受控環境之外的現實環境中尤其具有挑戰性。

即時處理 - 語音生物標記系統需要即時處理能力，這需要大量的運算資源。處理延遲或錯誤可能會導致錯誤識別和追蹤，尤其是在客服中心和公共場所等高流量環境中。

阻礙聲音/語音生物標記市場成長的其他挑戰包括：

  • 缺乏標準化法規

市場機會

  • 使用聲音/語音生物標記進行早期檢測和預防疾病

聲音/語音生物標記物提供了一種非侵入性且經濟有效的方法，可早期發現各種健康狀況，包括神經系統疾病（例如帕金森氏症、阿茲海默症）、心理健康問題（例如憂鬱症、焦慮症）以及呼吸系統疾病（例如睡眠呼吸中止症、COVID-19）。早期檢測有助於預防性護理和及時干預，改善患者預後並降低醫療成本。

Vocalis Health 利用人工智慧語音分析技術，透過分析語音模式的細微變化來檢測帕金森氏症的徵兆。讓偏遠地區和高風險族群更容易獲得此類技術，實現早期療育和個人化治療方案，這蘊藏著巨大的潛力。同樣，像 Sonde Health 這樣的應用程式利用語音生物標記來監測情緒困擾，可以採取主動干預措施並預防慢性精神疾病。

創造市場成長機會的其他因素包括：

  • 聲音/語音生物標記的臨床試驗數量不斷增加

市場趨勢

  • 將 AI/ML 整合到聲音/語音生物標記技術中

人工智慧和機器學習與聲音/語音生物標記技術的融合，代表著醫療保健診斷和監測能力的重大飛躍。這些技術不僅提供了非侵入式、即時和個人化的醫療保健解決方案，還為早期疾病檢測、遠端監測和預測分析開闢了新的途徑。儘管資料隱私和臨床檢驗的挑戰依然存在，但人工智慧和機器學習透過語音生物標記徹底改變醫療保健的潛力巨大，將在各種健康狀況的診斷和管理中帶來顯著益處。

本報告深入探討了聲音/語音生物標記的最新技術進步，使公司能夠推動創新並開發出滿足市場需求的尖端產品。

透過提供全面的市場分析和識別關鍵的成長機會，為公司提供知識來製定有針對性的行銷策略並有效地擴大其市場佔有率。

本報告包括全面的競爭格局分析，以幫助了解聲音/語音生物標記市場中競爭對手的優勢和劣勢，並制定有效的策略以在市場上獲得競爭優勢。

提供有關戰略性聲音/語音生物標記的法律規範、核准和行業指南的最新資訊，使公司能夠保持合規性並加速新聲音/語音生物標記的市場進入。

透過分析市場趨勢、資金籌措模式和合作機會，幫助公司做出明智的投資決策並發現潛在的併購機會以促進業務成長。

主要市場參與企業和競爭對手的摘要

公司簡介是根據從主要專家收集的意見以及對公司覆蓋範圍、產品系列和市場滲透率的分析而選擇的。

聲音/語音生物標記市場涵蓋了廣泛的技術，目的是分析和解讀語音資料，應用於從醫療診斷到客戶服務中的情緒智商等各種領域。隨著人工智慧和機器學習技術的持續進步，聲音/語音生物標記市場預計將快速成長，並影響醫療保健、安防、汽車、客戶服務和通訊等行業。隨著人們對非侵入性診斷、個人化服務和增強安全性的日益關注，語音生物標記技術將在許多領域發揮關鍵作用，尤其是在醫療保健和語音身份驗證領域擁有巨大的潛力。

在聲音/語音生物標記市場中知名的公司有：

  • Sonde Health
  • Canary Speech
  • Ellipsis Health
  • auddering GmbH
  • Cogito Tech
  • Kintsugi
  • Beyond Verbal

目錄

執行摘要

第1章 全球語音生物標記市場：產業展望

  • 產業展望
  • 市場動態
  • 趨勢

第2章 平台類型

  • 概述
  • 成長佔有率矩陣
    • 雲端基礎的平台
  • 網路為基礎的平台

第3章 應用類型

  • 概述
  • 成長佔有率矩陣
    • 監控
    • 診斷
    • 臨床研究
    • 其他

第4章 適應症

  • 概述
  • 成長佔有率矩陣
    • 精神障礙
    • 神經系統疾病
    • 呼吸系統疾病
    • 心血管疾病
    • 其他

第5章 最終用戶

  • 概述
  • 成長佔有率矩陣
    • 醫院
    • CRO
    • 研究所

第6章 區域

  • 北美洲
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 市場規模及預測
    • 美國
    • 加拿大
  • 歐洲
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 市場規模及預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 市場規模及預測
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 市場規模及預測
  • 中東和非洲
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 市場規模及預測

第7章 競爭格局與公司概況

  • 語音生物標記市場公司地位分析
  • 公司簡介
    • audEERING GmbH
    • Biosensics
    • Canary Speech, Inc.
    • EVOCAL Health GmbH
    • Kintsugi Mindful Wellness, Inc.
    • PST Inc.
    • Sonde Health
    • Sound Health
    • VoiceMed Italia srl
    • Zana Technologies GmbH

第8章 調查方法

Product Code: BHD3203SA

This report can be delivered within 1 working day.

Introduction of Voice/Vocal Biomarker Market

Voice/vocal biomarkers refer to the development, commercialization, and application of biological markers derived from human voice characteristics to detect, monitor, and predict health conditions. Voice/vocal biomarkers are a a part of digital biomarker and has measurable vocal features, such as pitch, tone, frequency, amplitude, speech rate, and tremor, which correlate with physiological or pathological states, enabling non-invasive diagnosis and monitoring. The voice/vocal biomarker market encompasses software platforms, AI and machine learning algorithms, hardware-enabled diagnostic tools, and integrated telehealth solutions that capture and analyze voice data to identify early signs of diseases including neurological disorders (e.g., Parkinson's, Alzheimer's), mental health conditions (e.g., depression, anxiety), respiratory illnesses, cardiovascular disease, and cognitive decline. It also covers applications in wellness, cognitive fitness, defense, and occupational health. Growth in this market has been fueled by technological advancements, the rising need for remote healthcare solutions, and the ability of vocal analysis to offer fast, scalable, and cost-effective screening compared to traditional diagnostic methods.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$1,243.5 Million
2035 Forecast$5,397.7 Million
CAGR15.81%

Market Introduction

The global voice/vocal biomarker market is expected to witness significant expansion, projected to reach 5,397.7 million by 2035.

Voice/vocal biomarkers are an emerging and innovative approach to diagnosing and monitoring various health conditions, primarily through the analysis of voice patterns and speech. The field is rapidly growing, with advancements in artificial intelligence (AI), machine learning, and natural language processing (NLP) enabling more accurate and non-invasive diagnostic tools.

Companies in the voice/vocal biomarker market like Sonde Health, Canary Speech, and Winterlight are leveraging AI-driven algorithms to analyze speech patterns for the detection of neurological, psychiatric, and cognitive disorders. These solutions assess vocal features such as pitch, tone, rhythm, and speed to identify early signs of diseases like Alzheimer's, Parkinson's, depression, and anxiety.

Voice/vocal biomarkers are being increasingly used to monitor cognitive impairment and other neurological conditions. The ability to detect subtle changes in voice and speech patterns allows for earlier interventions and more accurate disease progression tracking. This can significantly enhance the management of conditions like dementia and other age-related cognitive diseases.

One of the major advantages of vocal biomarker technology is its non-invasive nature. Unlike traditional diagnostic tools that require invasive procedures or extensive testing, vocal biomarkers use brief voice recordings (often just 30-40 seconds) to detect early indicators of health issues. This makes it a highly accessible tool for continuous monitoring, especially in remote settings.

Leading companies in the voice/vocal biomarker market space are forming strategic partnerships to enhance their capabilities and expand their market presence. For instance, Sonde Health has teamed up with Qualcomm to integrate its vocal biomarker technology into mobile platforms, enabling health monitoring through everyday devices. Additionally, Winterlight's acquisition by Cambridge Cognition highlights the growing emphasis on cognitive impairment detection via voice analysis.

The integration of vocal biomarker technology into healthcare systems is becoming more widespread, with applications in telemedicine, mental health, and cognitive health monitoring. These tools are increasingly being used in clinical settings, patient wellness programs, and research to track health status and detect early symptoms of diseases in a cost-effective and timely manner.

The voice/vocal biomarker market market is experiencing significant investment, driven by growing demand for innovative and non-invasive diagnostic solutions. Global voice/vocal biomarker market will continue to expand rapidly in the coming years, with applications not just limited to neurological and mental health but extending to chronic conditions like COPD and even detecting stress levels.

Despite the promising potential of vocal biomarkers, there are concerns around data privacy and the ethical use of voice data. As these technologies collect sensitive information about an individual's health, regulations like GDPR and HIPAA are essential to ensure privacy protection. Companies in the sector are focusing on ensuring that their solutions comply with data protection laws and that user data is securely handled.

In summary, global voice/vocal biomarker market positioning themselves as a transformative tool in healthcare, providing a non-invasive, accessible, and scalable solution for early detection and continuous monitoring of a wide array of health conditions. As technology advances, the integration of vocal biomarkers into everyday health applications is expected to significantly improve patient outcomes and healthcare efficiency.

Industrial Impact

Voice/vocal biomarker market are increasingly being used to monitor and diagnose a range of conditions such as neurodegenerative diseases (like Parkinson's or Alzheimer's), mental health disorders (like depression or anxiety), and respiratory diseases (such as asthma and COPD). For example, specific vocal changes can signal early-stage Parkinson's disease, which is traditionally difficult to diagnose early.

Voice-based Authentication: In industries where security and identity verification are paramount, vocal biomarkers are being used for voice biometrics. This involves analyzing a person's voice for unique characteristics (such as accent, tone, and speech rhythm) to authenticate identity. It's being adopted in banking, telecoms, and government sectors.

Impact: Improves security, reduces fraud, enhances user experience by enabling hands-free authentication.

In customer support, call centers, and virtual assistants (like Alexa or Siri), vocal biomarkers help detect emotions such as frustration, happiness, or stress. This allows companies to adapt responses accordingly or route customers to specialized agents based on their emotional state.

Market Segmentation

Segmentation 1: By Platform Type

  • Cloud-based
  • Web-based

Cloud-based remains the leading segment by platform type in the global voice/vocal Biomarker market, holding an 79.99% market share in 2024, with a projected CAGR of 16.0% during the forecast period 2025-2035.

Cloud-based platforms in the global voice/vocal biomarker market are transforming how voice data is collected, stored, processed, and analyzed. These platforms provide the infrastructure and computational power needed to process large volumes of speech data and apply AI algorithms for diagnostic and monitoring purposes. The emergence of cloud-based platforms for vocal biomarker analysis is reshaping the landscape of health diagnostics and remote patient monitoring. These platforms harness the power of AI and machine learning to interpret voice data, transforming vocal characteristics into actionable health insights. By leveraging scalable cloud infrastructure, they facilitate real-time, remote, and large-scale analysis, improving accessibility for clinicians, researchers, and digital health innovators.

Segmentation 2: By Indication Type

  • Neurological Disorder
  • Mental Health Disorder
  • Respiratory Diseases
  • Cardiovascular Disease
  • Others

Based on indication type, the global voice/vocal biomarker market was led by mental health disorder segment, which accounted for a 33.51% market share in 2024. Mental health disorders indication is dominating the voice/ vocal biomarkers market due to the increasing demand for non-invasive, real-time monitoring of emotional and psychological well-being. Voice analysis can detect stress, anxiety, depression, and other mental health conditions by analyzing tone, pitch, and speech patterns. For example, companies like Ellipsis Health have developed AI-powered platforms that assess mental health through voice recordings, enabling timely interventions and improving access to mental health care. This approach is gaining traction due to its ease of use and scalability.

Segmentation 3: By Application Type

  • Diagnostics
  • Monitoring
  • Clinical Research
  • Others

Based on application type, the global voice/vocal biomarker market market was led by diagnostics dominating the voice/ vocal biomarkers market. The diagnostics applications in the vocal biomarkers market is driven by the non-invasive nature of the technology, its ability to detect early signs of diseases, and its role in continuous monitoring of patient health. With advancements in AI, machine learning, and remote healthcare, vocal biomarkers provide a cost-effective, scalable, and accessible solution to improve the accuracy and timeliness of disease detection, particularly for neurological and respiratory conditions. As clinical validation progresses and the technology becomes more integrated into healthcare systems, the diagnostic applications of vocal biomarkers are expected to grow even further, offering significant benefits to both patients and healthcare providers.

Segmentation 4: By End User

  • Hospitals
  • CROs
  • Research Institutions

Based on end user, the global voice/vocal biomarker market market was led by the Hospitals and Clinics segment, which held a 47.02% share in 2024. Hospitals hold a dominant position in the vocal biomarker market, supported by several strategic strengths: their core involvement in diagnostics, expansive data repositories, mastery of regulatory frameworks, and robust financial backing combined with the trust they enjoy across healthcare networks. Their state-of-the-art infrastructure, cross-disciplinary synergies, and access to large patient populations make them optimal partners for the development, validation, and commercialization of vocal biomarker innovations. As these technologies evolve and gain maturity, hospitals are poised to remain at the forefront driving both clinical adoption and innovation in this emerging field.

Segmentation 5: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • India
    • China
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific
  • Latin America
  • Middle East and Africa

The global voice/vocal biomarker market market in the Asia-Pacific region is expanding rapidly. The voice/vocal biomarker market in APAC is poised for robust growth, particularly with the integration of AI and ML into mobile health devices, wearables, and telehealth services. However, regulatory frameworks and data privacy concerns need to be addressed to ensure long-term sustainability and widespread adoption.

With respect to countries of the APAC region, China holds the largest market share in the APAC region due to its large population and rapid technological adoption. India is emerging as one of the fastest-growing markets due to rising healthcare investments and an increasing burden of chronic diseases.

Companies such as Sonde Health, Beyond Verbal, Cogito Corporation, and Vocalis Health are leading the market by integrating AI technologies to enhance the capabilities of voice/vocal solutions..

Recent Developments in the Global Voice/Vocal Biomarker Market

  • In Jun-25: Beyond Verbal partnered with Mayo Clinic to develop and validate vocal biomarkers for early-stage Alzheimer's disease detection.
  • In Jun-25: Elipsis Health raised $45 million in Series A funding supported by Salesforce, Khosla Ventures, and CVS Health Ventures. This investment aims to enhance their AI-powered voice agents for care management
  • In Feb-25: Noah secured USD 406,214 Million to advance telemonitoring and voice diagnostics for heart diseases. Company explored the use of AI in voice-based diagnostics of heart diseases, analysing changes in vocal tone
  • In Dec-22: Sonde Health secured $19.25 million in Series B fundiing led by Partners Investment, with contributions from NEOM Company, KT Corporation, PureTech Health and M Ventures. With a total of $35.25 million raised, the company plans to use the capital to accelerate its global expansion.
  • In Aug-22: Sonde Health partnered with Koye Pharmaceuticals and entered a multi-year agreement to develop vocal biomarker detection and monitoring capabilities for Chronic Obstructive Pulmonary Disease (COPD) in India

Demand -Drivers, Challenges, and Opportunities

Market Demand Drivers:

  • Rising Application of Voice/Vocal Biomarkers as Novel Diagnostic and Monitoring Aid

Vocal biomarker technology represents a game-changer in the healthcare industry. Its non-invasive, cost-effective, and continuous nature makes it an attractive option for early diagnosis, monitoring disease progression, and managing various health conditions. By leveraging the natural variations in voice characteristics, clinicians can gain insights into a patient's health that would otherwise be difficult to detect. As these technologies continue to evolve, we can expect broader adoption across clinical settings, especially as AI algorithms improve and regulatory approvals streamline the integration of voice biomarkers into everyday healthcare. Vocal biomarker technology is being applied across various clinical domains as an innovative tool for diagnosis and monitoring.

Neurology: Neurological disorders such as Parkinson's disease, Alzheimer's, and multiple sclerosis often lead to subtle changes in voice patterns. Voice analysis can help detect early signs of these conditions or monitor their progression. For example, variations in vocal tremor, pitch, or timing may indicate motor impairments in Parkinson's disease or cognitive decline in dementia.

Mental Health: Mental health conditions, including depression, anxiety, and stress, can alter speech patterns and tone. AI algorithms can detect vocal cues, such as slower speech or flat intonation, associated with these conditions, facilitating continuous monitoring and early intervention. This allows for passive, non-intrusive screenings, such as identifying the risk of depression from a brief voice sample.

Cardiology: Research has shown that vocal characteristics can reflect cardiovascular health. Specific vocal patterns may be linked to heart conditions, with changes in speech due to congestion or breathing irregularities potentially signaling heart failure or coronary artery disease. Vocal biomarkers are being explored for early detection and ongoing monitoring of cardiac conditions alongside traditional methods.

Respiratory Disease: Respiratory conditions like chronic obstructive pulmonary disease (COPD) and asthma can affect voice and breathing sounds. Voice analysis can track wheezing, shortness of breath during speech, or coughing patterns, offering a non-invasive method to monitor respiratory health and detect exacerbations early. For example, vocal biomarkers are being tested to help manage COPD patients by analysing voice recordings to identify signs of declining lung function.

Other Clinical Uses: Vocal biomarkers are also being researched for detecting diabetic complications, cognitive impairments, traumatic brain injury, and monitoring stress or fatigue in high-risk professions. In general wellness and preventive care, vocal biomarkers provide a convenient way to monitor health, such as wellness apps tracking voice-derived stress levels as an early warning sign of potential health issues.

Note: All of the above factors will be evaluated in detail in the report.

Market Challenges:

  • Technology Limitations and Accuracy Issues

Variability in Voice Patterns: People's voices can vary widely based on factors like emotional state, health conditions, environmental noise, age, gender, and accent. Voice biomarker systems need to account for these variations to ensure accurate and reliable identification.

Signal Quality: Background noise, such as other voices or environmental sounds, can distort the voice signal, making it harder for the system to capture accurate biometric data. This is particularly challenging in real-world environments outside controlled settings.

Real-Time Processing: Voice biomarker systems require real-time processing capabilities, which can be computationally intensive. Delays or errors in processing may lead to incorrect identification or tracking, especially in high-traffic environments like call centers or public spaces.

Some of the other factors challenging the voice/vocal biomarker market growth include:

  • Lack of Standardized Regulation

Note: All of the above factors will be evaluated in detail in the report.

Market Opportunities:

  • Early Disease Detection and Prevention using Vocal Biomarkers

Voice/vocal biomarker provide a non-invasive and cost-effective means for early detection of a range of health conditions, including neurological disorders (e.g., Parkinson's disease, Alzheimer's disease), mental health issues (e.g., depression, anxiety), and respiratory conditions (e.g., sleep apnea, COVID-19). Early detection enables preventive care and timely interventions, which can lead to better patient outcomes and reduced healthcare costs.

Vocalis Health uses AI-powered voice analysis to detect signs of Parkinson's disease by analyzing subtle changes in speech patterns. The opportunity lies in scaling such technologies for widespread use in remote and at-risk populations, enabling earlier intervention and personalized treatment plans. Similarly, apps such as Sonde Health are leveraging vocal biomarkers to monitor emotional distress, which can indicate early signs of mental health conditions like depression and anxiety. This could lead to proactive interventions and the avoidance of chronic mental health conditions.

Some of the other factors creating an opportunity for market growth include:

  • Increasing Number of Clinical Trials on voice/vocal biomarker

Note: All of the above factors will be evaluated in detail in the report.

Market Trends:

  • Integration of AI/ML into Voice/Vocal Biomarker Technologies

The integration of AI and ML into voice/vocal biomarker technologies marks a significant leap forward in the diagnostic and monitoring capabilities of healthcare. These technologies not only provide non-invasive, real-time, and personalized healthcare solutions but also open up new avenues for early disease detection, remote monitoring, and predictive analytics. While challenges around data privacy and clinical validation remain, the potential for AI and ML to revolutionize healthcare through vocal biomarkers is immense, offering substantial benefits in the diagnosis and management of a wide array of health conditions.

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in voice/vocal biomarker, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses in Voice/Vocal Biomarker and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines specific to Voice/Vocal Biomarker, ensuring organizations stay compliant and accelerate market entry for new voice/vocal biomarker

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
  • The scope of this report has been carefully derived based on extensive interactions with experts and stakeholders across leading companies and research institutions worldwide. This report provides a comprehensive market analysis of robotics and non-robotics within the voice/vocal biomarker market.
  • Revenues of the companies have been referenced from their annual reports for FY2023 and FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available Voice/Vocal Biomarker products. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in Voice/Vocal Biomarker, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

The voice/vocal biomarker market encompasses a wide array of technologies designed to analyze and interpret voice data for various applications, from healthcare diagnostics to emotional intelligence in customer service. As technological advancements in AI and machine learning continue, the voice/vocal biomarker market is set to grow rapidly, impacting industries like healthcare, security, automotive, customer service, and telecommunications. With a growing focus on non-invasive diagnostics, personalized services, and enhanced security, vocal biomarker technologies are becoming a critical part of many sectors, with a particularly strong future in healthcare and voice authentication.

Some prominent names established in the voice/vocal biomarker market are:

  • Sonde Health
  • Canary Speech
  • Ellipsis Health
  • auddering GmbH
  • Cogito Tech
  • Kintsugi
  • Beyond Verbal

Table of Contents

Executive Summary

Scope and Definition

1 Global Voice/Vocal Biomarker Market: Industry Outlook

  • 1.1 Industry Outlook
    • 1.1.1 Market Overview and Ecosystem
      • 1.1.1.1 Future Direction and Emerging Technology
    • 1.1.2 Competitive Assessment
      • 1.1.2.1 Go-to-Market Strategy
      • 1.1.2.2 Competitive Landscape
        • 1.1.2.2.1 Business Strategies
    • 1.1.3 Opportunity Assessment
      • 1.1.3.1 Strategic Opportunities of Stakeholders in Voice/Vocal Biomarker Market
      • 1.1.3.2 Market Opportunity and Demand Analysis
    • 1.1.4 Funding Analysis
  • 1.2 Market Dynamics
    • 1.2.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
  • 1.3 Trends
    • 1.3.1 Integration of AI/ML into Vocal Biomarker Technologies
    • 1.3.2 Market Drivers
      • 1.3.2.1 Rising Application of Vocal Biomarkers as Novel Diagnostic and Monitoring Aid
      • 1.3.2.2 Increasing Demand for Remote and Non-Invasive Health Monitoring
      • 1.3.2.3 Adoption of Vocal Biomarkers in Health and Wellness Apps
    • 1.3.3 Market Restraints
      • 1.3.3.1 Regulatory Challenges and Unclear Guidelines
        • 1.3.3.1.1 Regulatory Approval for AI/ML-based Vocal Biomarker Applications
        • 1.3.3.1.2 Need for Clinical Validation
      • 1.3.3.2 Integration of Vocal Biomarker Technologies in Healthcare Systems and Associated Complexities
        • 1.3.3.2.1 Integration with EHR
        • 1.3.3.2.2 Integration with Telehealth Platforms
        • 1.3.3.2.3 Integration with Wearables and Smart Devices
    • 1.3.4 Market Opportunities
      • 1.3.4.1 Early Disease Detection and Prevention using Vocal Biomarkers
      • 1.3.4.2 Increasing Number of Clinical Trials and Research on Vocal Biomarker
    • 1.3.5 Market Challenges
      • 1.3.5.1 Technology Limitations and Accuracy Issues
      • 1.3.5.2 Lack of Standardized Regulations on Vocal Biomarker

2 Platform Type

  • 2.1 Overview
  • 2.2 Growth Share Matrix
    • 2.2.1 Cloud-Based Platform
  • 2.3 Web-Based Platform

3 Application Type

  • 3.1 Overview
  • 3.2 Growth Share Matrix
    • 3.2.1 Monitoring
    • 3.2.2 Diagnostics
    • 3.2.3 Clinical Research
    • 3.2.4 Others

4 Indication

  • 4.1 Overview
  • 4.2 Growth Share Matrix
    • 4.2.1 Mental Health Disorder
    • 4.2.2 Neurological Disorder
    • 4.2.3 Respiratory Diseases
    • 4.2.4 Cardiovascular Diseases
    • 4.2.5 Others

5 End User

  • 5.1 Overview
  • 5.2 Growth Share Matrix
    • 5.2.1 Hospitals
    • 5.2.2 CROs
    • 5.2.3 Research Institutions

6 Region

  • 6.1 North America
    • 6.1.1 Regional Overview
    • 6.1.2 Driving Factors for Market Growth
    • 6.1.3 Factors Challenging the Market
    • 6.1.4 Market Sizing and Forecast
      • 6.1.4.1 North America Voice/Vocal Biomarkers Market, by Platform Type
      • 6.1.4.2 North America Voice/Vocal Biomarkers Market, by Application
      • 6.1.4.3 North America Voice/Vocal Biomarkers Market, by Indication
      • 6.1.4.4 North America Voice/Vocal Biomarkers Market, by End User
      • 6.1.4.5 North America Voice/Vocal Biomarkers Market, by Country
    • 6.1.5 U.S.
      • 6.1.5.1 Country Overview
        • 6.1.5.1.1 Market Sizing and Forecast
    • 6.1.6 Canada
      • 6.1.6.1 Country Overview
        • 6.1.6.1.1 Market Sizing and Forecast
  • 6.2 Europe
    • 6.2.1 Regional Overview
    • 6.2.2 Driving Factors for Market Growth
    • 6.2.3 Factors Challenging the Market
    • 6.2.4 Market Sizing and Forecast
      • 6.2.4.1 Europe Voice/Vocal Biomarkers Market, by Platform Type
      • 6.2.4.2 Europe Voice/Vocal Biomarkers Market, by Application
      • 6.2.4.3 Europe Voice/Vocal Biomarkers Market, by Indication
      • 6.2.4.4 Europe Voice/Vocal Biomarkers Market, by End User
      • 6.2.4.5 Europe Voice/Vocal Biomarkers Market, by Country
    • 6.2.5 U.K.
      • 6.2.5.1 Country Overview
        • 6.2.5.1.1 Market Sizing and Forecast
    • 6.2.6 Germany
      • 6.2.6.1 Country Overview
        • 6.2.6.1.1 Market Sizing and Forecast
    • 6.2.7 France
      • 6.2.7.1 Country Overview
        • 6.2.7.1.1 Market Sizing and Forecast
    • 6.2.8 Italy
      • 6.2.8.1 Country Overview
        • 6.2.8.1.1 Market Sizing and Forecast
    • 6.2.9 Spain
      • 6.2.9.1 Country Overview
        • 6.2.9.1.1 Market Sizing and Forecast
    • 6.2.10 Rest-of-the- Europe
      • 6.2.10.1 Country Overview
        • 6.2.10.1.1 Market Sizing and Forecast
  • 6.3 Asia-Pacific
    • 6.3.1 Regional Overview
    • 6.3.2 Driving Factors for Market Growth
    • 6.3.3 Factors Challenging the Market
    • 6.3.4 Market Sizing and Forecast
      • 6.3.4.1 Asia-Pacific Voice/Vocal Biomarkers Market, by Platform Type
      • 6.3.4.2 Asia-Pacific Voice/Vocal Biomarkers Market, by Application
      • 6.3.4.3 Asia-Pacific Voice/Vocal Biomarkers Market, by Indication
      • 6.3.4.4 Asia-Pacific Voice/Vocal Biomarkers Market, by End User
      • 6.3.4.5 Asia-Pacific Voice/Vocal Biomarkers Market, by Country
    • 6.3.5 China
      • 6.3.5.1 Country Overview
        • 6.3.5.1.1 Market Sizing and Forecast
    • 6.3.6 Japan
      • 6.3.6.1 Country Overview
        • 6.3.6.1.1 Market Sizing and Forecast
    • 6.3.7 India
      • 6.3.7.1 Country Overview
        • 6.3.7.1.1 Market Sizing and Forecast
    • 6.3.8 Australia
      • 6.3.8.1 Country Overview
        • 6.3.8.1.1 Market Sizing and Forecast
    • 6.3.9 South Korea
      • 6.3.9.1 Country Overview
        • 6.3.9.1.1 Market Sizing and Forecast
    • 6.3.10 Rest-of-the- Asia-Pacific
      • 6.3.10.1 Country Overview
        • 6.3.10.1.1 Market Sizing and Forecast
  • 6.4 Latin America
    • 6.4.1 Regional Overview
    • 6.4.2 Driving Factors for Market Growth
    • 6.4.3 Factors Challenging the Market
    • 6.4.4 Market Sizing and Forecast
      • 6.4.4.1 Latin America Voice/Vocal Biomarkers Market, by Platform Type
      • 6.4.4.2 Latin America Voice/Vocal Biomarkers Market, by Application
      • 6.4.4.3 Latin America Voice/Vocal Biomarkers Market, by Indication
      • 6.4.4.4 Latin America Voice/Vocal Biomarkers Market, by End User
  • 6.5 Middle East and Africa
    • 6.5.1 Regional Overview
    • 6.5.2 Driving Factors for Market Growth
    • 6.5.3 Factors Challenging the Market
    • 6.5.4 Market Sizing and Forecast
      • 6.5.4.1 Middle East and Africa Voice/Vocal Biomarkers Market, by Platform Type
      • 6.5.4.2 Middle East and Africa Voice/Vocal Biomarkers Market, by Application
      • 6.5.4.3 Middle East and Africa Voice/Vocal Biomarkers Market, by Indication
      • 6.5.4.4 Middle East and Africa Voice/Vocal Biomarkers Market, by End User

7 Competitive Landscape and Company Profiles

  • 7.1 Company Position Analysis in Voice/Vocal Biomarkers Market
  • 7.2 Company Profiles
    • 7.2.1 audEERING GmbH
      • 7.2.1.1 Overview
    • 7.2.2 Biosensics
      • 7.2.2.1 Overview
    • 7.2.3 Canary Speech, Inc.
      • 7.2.3.1 Overview
    • 7.2.4 EVOCAL Health GmbH
      • 7.2.4.1 Overview
    • 7.2.5 Kintsugi Mindful Wellness, Inc.
      • 7.2.5.1 Overview
    • 7.2.6 PST Inc.
      • 7.2.6.1 Overview
    • 7.2.7 Sonde Health
      • 7.2.7.1 Overview
    • 7.2.8 Sound Health
      • 7.2.8.1 Overview
    • 7.2.9 VoiceMed Italia srl
      • 7.2.9.1 Overview
    • 7.2.10 Zana Technologies GmbH
      • 7.2.10.1 Overview

8 Research Methodology

  • 8.1 Data Sources
    • 8.1.1 Primary Data Sources
    • 8.1.2 Secondary Data Sources
    • 8.1.3 Inclusion and Exclusion
    • 8.1.4 Data Triangulation
  • 8.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Voice/Vocal Biomarker Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Global Voice/Vocal Biomarker Market, 2024-2035
  • Figure 3: Top 10 Countries, Global Voice/Vocal Biomarker Market, $Million, 2024
  • Figure 4: Global Voice/Vocal Biomarker Market Snapshot
  • Figure 5: Global Voice/Vocal Biomarker Market, $Million, 2024 and 2035
  • Figure 6: Voice/Vocal Biomarker Market (by Platform Type), $Million, 2024, 2028, and 2035
  • Figure 7: Voice/Vocal Biomarker Market (by Application Type), $Million, 2024, 2028, and 2035
  • Figure 8: Voice/Vocal Biomarker Market (by Indication Type), $Million, 2024, 2028, and 2035
  • Figure 9: Voice/Vocal Biomarker Market (by End User), $Million, 2024, 2028, and 2035
  • Figure 10: Voice/Vocal Biomarker Market Segmentation
  • Figure 11: Go-to-Market Strategy of Major Players
  • Figure 12: Go-to-Market Strategy of Major Players
  • Figure 13: Go-to-Market Strategy of Major Players
  • Figure 14: Companies Offering AI-based Vocal Biomarkers for Early Disease Detection
  • Figure 15: Global Voice/Vocal Biomarkers Market, by Platform Type, $Million, 2024, 2028, and 2035
  • Figure 16: Key Value Propositions of Cloud-Based Vocal Biomarker Platforms
  • Figure 17: Cloud-based Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 18: Web-Based Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 19: Global Voice/Vocal Biomarker Market, by Patient Type, $Million, 2024, 2028, and 2035
  • Figure 20: Global Voice/Vocal Biomarker Market, by Monitoring, $Million, 2024-2035
  • Figure 21: Global Voice/Vocal Biomarker Market, by Diagnostics, $Million, 2024-2035
  • Figure 22: Global Voice/Vocal Biomarker Market, by Clinical Research, $Million, 2024-2035
  • Figure 23: Global Voice/Vocal Biomarker Market, by Others, $Million, 2024-2035
  • Figure 24: Global Voice/Vocal Biomarker Market, by Indication, $Million, 2024, 2028, and 2035
  • Figure 25: Global Voice/Vocal Biomarker Market, by Mental Health Disorder, $Million, 2024-2035
  • Figure 26: Global Voice/Vocal Biomarker Market, by Neurological Disorder, $Million, 2024-2035
  • Figure 27: Global Voice/Vocal Biomarker Market, by Respiratory Diseases, $Million, 2024-2035
  • Figure 28: Global Voice/Vocal Biomarker Market, by Cardiovascular Diseases, $Million, 2024-2035
  • Figure 29: Global Voice/Vocal Biomarker Market, by Others, $Million, 2024-2035
  • Figure 30: Global Voice/Vocal Biomarker Market, by End User, $Million, 2024, 2028, and 2035
  • Figure 31: Global Voice/Vocal Biomarker Market, by Hospitals, $Million, 2024-2035
  • Figure 32: Global Voice/Vocal Biomarker Market, by CROs, $Million, 2024-2035
  • Figure 33: Global Voice/Vocal Biomarker Market, by Research Institutions, $Million, 2024-2035
  • Figure 34: North America Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 35: U.S. Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 36: Canada Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 37: Europe Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 38: U.K. Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 39: Germany Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 40: France Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 41: Italy Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 42: Spain Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 43: Rest-of-the Europe Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 44: Asia Pacific Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 45: China Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 46: Japan Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 47: India Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 48: Australia Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 49: South-Korea Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 50: Rest-of-the Asia-Pacific Voice/Vocal BIomarkers Market, $Million, 2024-2035
  • Figure 51: Latin America Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 52: Middle East and Africa Voice/Vocal Biomarkers Market, $Million, 2024-2035
  • Figure 53: Inclusion and Exclusion Criteria for Global Voice/Vocal Biomarker Market
  • Figure 54: Data Triangulation
  • Figure 55: Top-Down and Bottom-Up Approach
  • Figure 56: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Recent Funding in Global Voice/Vocal Biomarker Market
  • Table 3: Use of AI/ML Technology by Companies
  • Table 4: Key Market Players and their Major Contributions
  • Table 5: Few Clinical Trials Related to Voice Biomarker
  • Table 6: Companies using Platform for Voice/Vocal Biomarker
  • Table 7: Global Voice/Vocal Biomarkers Market (by Region), $Million, 2024-2035
  • Table 8: North America Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
  • Table 9: North America Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
  • Table 10: North America Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
  • Table 11: North America Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
  • Table 12: North America Voice/Vocal Biomarkers Market (by Country), $Million, 2024-2035
  • Table 13: Europe Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
  • Table 14: Europe Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
  • Table 15: Europe Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
  • Table 16: Europe Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
  • Table 17: Europe Voice/Vocal Biomarkers Market (by Country), $Million, 2024-2035
  • Table 18: Asia-Pacific Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
  • Table 19: Asia-Pacific Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
  • Table 20: Asia-Pacific Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
  • Table 21: Asia-Pacific Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
  • Table 22: Asia-Pacific Voice/Vocal Biomarkers Market (by Country), $Million, 2024-2035
  • Table 23: Latin America Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
  • Table 24: Latin America Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
  • Table 25: Latin America Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
  • Table 26: Latin America Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
  • Table 27: Middle East and Africa Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
  • Table 28: Middle East and Africa Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
  • Table 29: Middle East and Africa Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
  • Table 30: Middle East and Africa Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035